Withdrawal of long‐term epoprostenol therapy in pulmonary arterial hypertension (PAH)
Author:
Affiliation:
1. Service de PneumologieFédération de médecine translationnelle de StrasbourgNouvel Hôpital CivilUniversité de StrasbourgStrasbourgFrance
2. Service de CardiologieNouvel Hôpital CivilUniversité de StrasbourgFrance
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045893217702401
Reference16 articles.
1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galiè N;Eur Heart J,2016
2. Survival in primary pulmonary hypertension with long‐term continuous intravenous prostacyclin;Barst RJ;Ann Intern Med,1994
3. Reduction in pulmonary vascular resistance with long‐term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension;McLaughlin VV;N Engl J Med,1998
4. Long‐term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival;Sitbon O;J Am Coll Cardiol,2002
5. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy;McLaughlin VV;Circulation,2002
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting;Journal of Cardiovascular Pharmacology and Therapeutics;2024-01
2. Anesthesia and pulmonary hypertension: A narrative review;Heart and Mind;2023
3. Pause at Your Own Peril: A Case Series on Rebound Pulmonary Hypertension;Cureus;2022-05-31
4. Successful epoprostenol withdrawal and termination with an aid of the exercise stress test in pulmonary arterial hypertension;International Journal of Cardiology;2022-01
5. Strategies for optimizing intravenous prostacyclin-analog therapy in patients with pulmonary arterial hypertension;Expert Review of Respiratory Medicine;2021-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3